EUVIMEDEUVIMED entdecken
Crossref

Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis

Halil Ibrahim Ellez iD, Nilay Danis iD, Ulus Salih Akarca iD

Acta Gastro Enterologica Belgica · 2024

DOI: 10.51821/87.2.12041 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Gastro Enterologica Belgica, 2024. Verfasst von Halil Ibrahim Ellez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Medical Oncology, Dokuz Eylul University, Izmir, Turkey. Hauptthemen laut MEDLINE: Alkaline Phosphatase, Liver Cirrhosis, Biliary, Autoantibodies. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary Biliary Cholangitis (PBC) is a chronic cholestatic liver disease typically diagnosed by elevated cholestatic liver enzymes and a positive anti-mitochondrial antibody (AMA) test. The clinical importance of AMA positivity in patients with normal cholestatic liver enzymes is unclear. The aim of this study was to determine the relationship between PBC and AMA positivity detected in individuals with normal cholestatic enzyme levels. The files of patients with AMA and/or AMA-M2 positivity between 2009 and 2018 and whose alkaline phosphatase (ALP) levels were below upper limit of normal (ULN) at initial admission were retrospectively analyzed. The ALP levels were normal in all patients. All patients had AMA positivity demonstrated by indirect immunofluorescence (IIF) or AMA-M2 positivity demonstrated by ELISA. A total of 16 patients underwent liver biopsy and seven (43.75%) showed changes consistent with those with PBC. A total of 12 patients were diagnosed with PBC and were treated and followed up with this diagnosis. People with AMA positivity and normal cholestasis enzyme levels are closely associated with PBC. Some of these patients were diagnosed with PBC as a result of biopsy and some were diagnosed by clinical and laboratory findings during follow-up.. The patients with an AMA titration of 1/20 were not associated with PBC. In our study, results similar to the studies confirmed by biopsies were obtained. In this regard, there is a need for prospective and retrospective studies with longer follow-up periods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alkaline PhosphataseLiver Cirrhosis, BiliaryAutoantibodiesHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedMitochondriaLiverBiopsy

Stichwörter der Autor:innen

alkaline phosphataseprimary biliary cholangitis

Substanzen

Alkaline PhosphataseAutoantibodies

Autor:innen und Institutionen

  • Department of Internal Medicine, Division of Medical Oncology, Dokuz Eylul University, Izmir, Turkey.
  • Department of Internal Medicine, Division of Gastroenterology, Dokuz Eylul University, Izmir, Turkey.
  • Department of Internal Medicine, Division of Gastroenterology, Ege University, Izmir, Turkey.

ORCID-Profile: Halil Ibrahim Ellez, Nilay Danis, Ulus Salih Akarca

Zitieren

APA

Ellez, H. I., Danis, N., & Akarca, U. S. (2024). Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/87.2.12041

Vancouver

Ellez HI, Danis N, Akarca US. Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis. Acta Gastro Enterologica Belgica. 2024. doi:10.51821/87.2.12041

BibTeX
@article{Ellez2024,
  author = {Ellez, Halil Ibrahim and Danis, Nilay and Akarca, Ulus Salih},
  title = {Evaluation of patients with positive anti-mitochondiral antibody and normal alkaline phosphatase levels for primary biliary cholangitis},
  journal = {Acta Gastro Enterologica Belgica},
  year = {2024},
  doi = {10.51821/87.2.12041}
}
Kostenlos starten →